Restart Life Sciences Company Description

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide.

It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome.

The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024.

Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.

Restart Life Sciences Corp.

Country	Canada
Founded	2004
Industry	Biotechnology
Sector	Healthcare
CEO	Steve Loutskou

Contact Details

Address: 700-838 West Hasting Street Vancouver, British Columbia V6C 0A6 Canada
Phone	778 819 0244
Website	restartlife.co

Stock Details

Ticker Symbol	NMLSF
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA66980V1067
SIC Code	2836

Key Executives

Name	Position
Steve Loutskou	President, Chief Executive Officer and Executive Chairman
Rebecca Lynn Hudson C.A., CPA	Chief Financial Officer
Dr. Aylia Mohammadi B.Sc., M.Sc., Ph.D.	President and Chief Scientific Officer of Nova Mentis Biotech Corporate
Kelly Pladson	Corporate Secretary